| Univariate |
P-value |
OR |
95% CI |
Multivariate |
P-value |
Adjusted OR |
95% CI |
| Age (per year) |
0.099 |
1.024 |
0.996 – 1.052 |
Age (per year) |
0.064 |
1.027 |
0.998 – 1.057 |
| Gender male |
0.237 |
0.664 |
0.337 – 1.309 |
Killip Class >1 |
0.008 |
2.784 |
1.310 – 5.919 |
| BMI |
0.182 |
0.936 |
0.849 – 1.032 |
Tirofiban study medication |
0.818 |
1.078 |
0.568 – 2.044 |
| Current smoker |
0.614 |
1.178 |
0.623 – 2.225 |
|
|
|
|
| Diabetes |
0.835 |
0.894 |
0.311 – 2.570 |
|
|
|
|
| Hypertension |
0.120 |
0.550 |
0.259 – 1.169 |
|
|
|
|
| Hypercholesterolaemia |
0.347 |
0.685 |
0.311 – 1.507 |
|
|
|
|
| Killip Class >1 |
0.010 |
2.694 |
1.273 – 5.702 |
|
|
|
|
| Previous MI |
0.830 |
0.877 |
0.263 – 2.919 |
|
|
|
|
| Previous PCI |
0.199 |
0.269 |
0.036 – 1.991 |
|
|
|
|
| Previous CABG |
0.590 |
1.768 |
0.223 – 14.035 |
|
|
|
|
| Systolic BP (per 10 mm Hg) |
0.106 |
0.895 |
0.782 – 1.024 |
|
|
|
|
| Diastolic BP (per 10 mm Hg) |
0.723 |
0.963 |
0.780 – 1.187 |
|
|
|
|
| Tirofiban study medication |
0.986 |
0.994 |
0.531 – 1.863 |
|
|
|
|
| Culprit Vessel RCA* |
0.887 |
0.930 |
0.339 – 2.547 |
|
|
|
|
| Culprit Vessel LAD* |
0.757 |
0.849 |
0.303 – 2.384 |
|
|
|
|
| TIMI grade flow post PCI <3 |
0.070 |
2.197 |
0.938 – 5.146 |
|
|
|
|
| NT-proBNP baseline (per 1000 increase) |
0.473 |
1.044 |
0.928 – 1.174 |
|
|
|
|
| HScTnT (per 0.1 increase) |
0.556 |
0.988 |
0.949 – 1.029 |
|
|
|
|
